The effect of gamma-hydroxybutyrate on mouse striatal tyramine, dopamine and homovanillic acid
- PMID: 7066598
- PMCID: PMC2071564
- DOI: 10.1111/j.1476-5381.1982.tb09160.x
The effect of gamma-hydroxybutyrate on mouse striatal tyramine, dopamine and homovanillic acid
Abstract
1 The concentrations of p- and m-tyramine, dopamine and homovanillic acid were measured in the mouse striatum following the subcutaneous injection of gamma-hydroxybutyrate; their control levels were 19.8, 6.3, 9600 and 1130 ng/g respectively. 2 The administration of 500-1000 mg/kg of gamma-hydroxybutyrate produced a reduction in p-tyramine that lasted at least 8 h. m-Tyramine and dopamine were significantly increased for at least 4 h. The levels of homovanillic acid were increased at 1 and 2 h after drug administration. 3 There experiments strongly suggest that the increases in dopamine turnover produced by gamma-hydroxybutyrate caused reciprocal changes in striatal tyramine that are similar to those produced by drug or treatment that increase dopamine turnover and tyrosine hydroxylase activity.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
